Matrix Metalloproteinase (MMP)-8 and MMP-9 in Cerebrospinal Fluid during Bacterial Meningitis: Association with Blood-Brain Barrier Damage and Neurological Sequelae
Open Access
- 1 July 2000
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 31 (1) , 80-84
- https://doi.org/10.1086/313922
Abstract
To evaluate the spectrum and regulation of matrix metalloproteinases (MMPs) in bacterial meningitis (BM), concentrations of MMP-2, MMP-3, MMP-8, andKeywords
This publication has 30 references indexed in Scilit:
- Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988JAMA, 1997
- Brain injury in bacterial meningitisCurrent Opinion in Neurology, 1997
- Treatment of Bacterial MeningitisNew England Journal of Medicine, 1997
- Reactive oxygen intermediates contribute to necrotic and apoptotic neuronal injury in an infant rat model of bacterial meningitis due to group B streptococci.Journal of Clinical Investigation, 1996
- Dexamethasone and bacterial meningitis in Pakistan.Archives of Disease in Childhood, 1996
- Tumor necrosis factor-α-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic windowBrain Research, 1995
- Proteolytic remodeling of extracellular matrixCurrent Opinion in Cell Biology, 1995
- Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases.Journal of Clinical Investigation, 1994
- A Comparison of Ceftriaxone and Cefuroxime for the Treatment of Bacterial Meningitis in ChildrenNew England Journal of Medicine, 1990
- Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response.The Journal of Experimental Medicine, 1989